Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Non-cash Items (2016 - 2025)

Plus Therapeutics (PSTV) has disclosed Non-cash Items for 13 consecutive years, with $1103.0 as the latest value for Q3 2025.

  • On a quarterly basis, Non-cash Items fell 99.0% to $1103.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $1103.0, a 99.0% decrease, with the full-year FY2023 number at $72843.0, down 89.16% from a year prior.
  • Non-cash Items was $1103.0 for Q3 2025 at Plus Therapeutics, down from $308724.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $1.4 million in Q2 2023 to a low of $149.0 in Q1 2021.
  • A 5-year average of $363840.3 and a median of $154830.0 in 2024 define the central range for Non-cash Items.
  • Peak YoY movement for Non-cash Items: skyrocketed 739575.84% in 2022, then plummeted 99.66% in 2023.
  • Plus Therapeutics' Non-cash Items stood at $343.0 in 2021, then soared by 195786.88% to $671892.0 in 2022, then tumbled by 89.16% to $72843.0 in 2023, then skyrocketed by 51.93% to $110674.0 in 2024, then crashed by 99.0% to $1103.0 in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Non-cash Items are $1103.0 (Q3 2025), $308724.0 (Q2 2025), and $198986.0 (Q1 2025).